Get the Stockscreener App
4.11
0.48%
-0.02
After Hours:
4.05
-0.06
-1.46%
Clene Inc stock is traded at $4.11, with a volume of 33,959.
It is down -0.48% in the last 24 hours and down -20.66% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$4.13
Open:
$4.09
24h Volume:
33,959
Relative Volume:
0.21
Market Cap:
$48.41M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-0.9215
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
+4.85%
1M Performance:
-20.66%
6M Performance:
+11.08%
1Y Performance:
-10.65%
1-Day Range:
$4.01
$4.245
1-Week Range:
$3.955
$4.60
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
4.11 | 48.64M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Top Nanotechnology Stocks To ResearchFebruary 12th - MarketBeat
Promising Nanotechnology Stocks To Add to Your WatchlistFebruary 10th - MarketBeat
Performance Recap: Whats the profit margin of Clene Inc Equity Warrant2025 Investor Takeaways & Accurate Trade Setup Notifications - baoquankhu1.vn
Top Nanotechnology Stocks To Follow NowFebruary 7th - MarketBeat
Aug Patterns: Is Clene Inc Equity Warrant a good stock for dollar cost averaging2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Nanotechnology Stocks To Keep An Eye OnFebruary 3rd - MarketBeat
Aug Mood: Is Clene Inc a strong growth stockOil Prices & Weekly Return Optimization Alerts - baoquankhu1.vn
Stock Market Recap: Is Clene Inc a strong growth stockEarnings Growth Summary & Verified Swing Trading Watchlists - baoquankhu1.vn
Published on: 2026-02-03 15:42:06 - baoquankhu1.vn
Nanotechnology Stocks To ConsiderFebruary 2nd - MarketBeat
Tech Rally: Should I invest in Clene Inc before earnings2025 Market WrapUp & Reliable Breakout Forecasts - baoquankhu1.vn
Top Nanotechnology Stocks Worth WatchingJanuary 31st - MarketBeat
Aug Decliners: Is Clene Inc a play on infrastructure spendingGlobal Markets & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Investment Recap: Is NPK International Inc impacted by rising rates2025 Top Decliners & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Volatility Watch: Does LAES have a competitive edge2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayJanuary 30th - MarketBeat
Big Picture: Is AMERISAFE Inc benefiting from innovation trendsTrade Risk Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Nanotechnology Stocks Worth WatchingJanuary 29th - MarketBeat
Will Clene Inc. Equity Warrant outperform during market ralliesJuly 2025 Short Interest & High Yield Stock Recommendations - mfd.ru
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 8,717 Shares of Stock - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 6,418 Shares of Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,139 Shares - MarketBeat
Resistance Check: What is the Moat Score of Clene Inc2025 EndofYear Setup & Free Verified High Yield Trade Plans - baoquankhu1.vn
Published on: 2026-01-28 21:39:04 - baoquankhu1.vn
Best Nanotechnology Stocks To Add to Your WatchlistJanuary 27th - MarketBeat
Breakout Watch: Will Clene Inc benefit from AI trendsPortfolio Gains Summary & Capital Protection Trade Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Follow TodayJanuary 25th - MarketBeat
Aug Breakouts: Should I buy Tile Shop Holdings Inc stock now2025 Trading Volume Trends & AI Based Trade Execution Alerts - baoquankhu1.vn
Chidozie Ugwumba Sells 12,665 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 5,556 Shares of Stock - MarketBeat
Technical Analysis: How do insiders feel about Clene Inc Equity WarrantQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Watch NowJanuary 23rd - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Clene Conference: FDA Grants Type C Meeting as CLNN Eyes ALS CNM-Au8 Accelerated Approval in Q2 - Yahoo Finance
Nanotechnology Stocks To Watch NowJanuary 22nd - MarketBeat
Chidozie Ugwumba Sells 12,119 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 7,923 Shares - MarketBeat
Chidozie Ugwumba Sells 12,432 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene Inc. ten percent owner sells $161k in shares By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $161k in shares - Investing.com
CLNN: FDA to review ALS therapy data this quarter; NDA filing and commercialization targeted for 2025 - TradingView
Should I hold or sell Regency Centers Corporation nowQuarterly Trade Report & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Insider Buy: What is the PEG ratio of Clene Inc2025 Trading Recap & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream - Investing News Network
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Growth Value: Will PG E Corporation Preferred Security benefit from rising consumer demandSell Signal & Intraday High Probability Alerts - baoquankhu1.vn
Trading Action: Is Clene Inc exposed to currency risksEarnings Growth Report & High Conviction Investment Ideas - baoquankhu1.vn
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):